Valuation GSK plc Xetra

Stocks

Real-time Estimate Tradegate Other stock markets 13:54:13 30/07/2026 +04			5-day change	1st Jan Change
22.97 ^EUR	-1.84%		+2.87%	+9.03%

01:06pm	Relation Therapeutics Limited and Glaxosmithkline plc Announce Expanded Collaboration to Generate Large-Scale Human Cellular Perturbation Datasets	CI
12:49pm	Berenberg raises Rio Tinto; HSBC ups Centrica	AN

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	79,929	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	9.19%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	100,203	93,113	89,906
Change	-	-24.65%	-1.89%	-8.24%	28.83%	14.32%	-7.07%	-3.45%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	13.2x	11.7x	11.3x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.63x	3.88x	3.35x
PEG	-	0x	-0.2x	-0.4x	0x	1.72x	0.9x	2.82x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.35x	2.24x	2.17x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.95x	2.61x	2.44x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.91x	7.4x	6.93x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.76x	8.35x	7.73x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	17.6x	15.3x	13.9x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	5.69%	6.55%	7.18%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6958	0.7315	0.7632
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.47%	3.64%	3.8%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.519	1.712	1.781
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	45.8%	42.7%	42.9%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,990	35,623	36,789
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,248	12,582	12,979
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,270	11,153	11,628
Net income ¹	4,385	14,956	4,928	2,575	5,716	6,138	6,958	7,126
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	20,273	13,184	9,976
Reference price ²	20.08	14.38	14.50	13.46	18.24	20.07	20.07	20.07
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	3,982,536	-	-
Announcement Date	09/02/22	01/02/23	31/01/24	05/02/25	04/02/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.93x	12.83x	26.95x	0.56%	1,079B
JOHNSON & JOHNSON	28.47x	6.51x	18.01x	2.02%	640B
ABBVIE INC.	33.14x	7.75x	15.92x	2.61%	465B
ROCHE HOLDING AG	20.04x	4.79x	11.87x	2.76%	353B
NOVARTIS AG	22.45x	5.8x	14.46x	2.76%	301B
ASTRAZENECA PLC	22.33x	4.59x	13.01x	1.91%	271B
NOVO NORDISK A/S	14.91x	5.52x	11.38x	3.36%	228B
AMGEN INC.	25.46x	6.65x	11.72x	2.6%	209B
GILEAD SCIENCES, INC.	-47.83x	5.73x	31.65x	2.48%	165B
Average	17.21x	6.69x	17.22x	2.34%	412.19B
Weighted average by Cap.	25.10x	8.05x	18.96x	1.93%